Joanna King
Jane Batt, St. Michael's Hospital
Mechanisms Regulating Chronic Skeletal Muscle Atrophy and Weakness in the Critical Illness Survivor
Susan Bronskill and Paula Rochon, Women's College Hospital
Understanding the burden and health system impact of loneliness and social isolation in older adults in Canada
Naoto Hirano and David Cescon, University Health Network
Development of a novel mesothelin CAR-T immunotherapy and pharmacologic combinations for triple negative breast cancer
Mansoor Husain, University Health Network
Cardiovascular effects of GLP-1(28-36): focus on heart failure
David Juurlink, Sunnybrook Research Institute
Studies on the safety of prescription opioids
Sonya Macparland and Jordan Feld, University Health Network
The Immunological Impact of Direct Acting Antiviral Treatment for Early HCV Infection
Connie Marras, University Health Network
Non-steroidal anti-inflammatory drugs and Parkinson's disease progression
Allison Mcgeer, Sinai Health System
PReventing the Emergence of CPE In hospitalS: understanding key Epidemiologic parameters (PRECISE)
Lisa Puchalski-Ritchie and Fernando Althabe, St. Michael's Hospital
Development and evaluation of a toolkit to support low- and middle-income country implementers' through the steps of effective implementation planning to improve uptake of evidence into practice and maternal health outcomes.
Annie Sawka, University Health Network
Active surveillance or surgery for primary management of very low risk papillary thyroid cancer: How often are the long-term disease management goals achieved?
Rachel Wald and Mark Friedberg, University Health Network
Right Ventricular Myocardial Fibrosis from Bench-to-Bedside: Implications for Care
Ron Wald and Michael Walsh, St. Michael's Hospital
Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)
Lihi Eder, Women's College Hospital, Priority Announcement: Musculoskeletal, Skin and Oral Health: Clinical Research - Skin Health
Derivation and Validation of a Disease-Specific Cardiovascular Risk Prediction Score for Psoriatic Disease Using Patient Registry and Population-Based Data